News | Radiology Business | October 25, 2018

Etta Pisano Named American College of Radiology Chief Research Officer

Principal investigator of two landmark mammography trials will identify clinical and socioeconomic research opportunities for ACR

Etta Pisano Named American College of Radiology Chief Research Officer

October 25, 2018 — Breast imaging research pioneer Etta Pisano, M.D., FACR, has been named chief research officer (CRO) of the American College of Radiology. Pisano is the first woman to hold this ACR position. She previously served as chief science officer (CSO) solely for of the ACR Center for Research and Innovation (CRI).

“Dr. Pisano is a giant in the clinical research community. She will identify clinical and socioeconomic research opportunities that can advance the practice of radiology and improve patient care. We are proud to have her as chief research officer for the entire College which will allow us to tap her talents and experience across the ACR,” said William T. Thorwarth, M.D., FACR, chief executive officer of the American College of Radiology.  

Pisano may be best known for leading landmark clinical research trials. She is principal investigator for the Tomosynthesis Mammographic Imaging Screening Trial (TMIST). Involving nearly 165,000 women, TMIST compares standard digital mammography (2-D) to digital breast tomosynthesis (DBT) to determine if DBT is more effective at reducing advanced breast cancers. TMIST will create the world’s largest aggregation of data, images and biospecimens arising from a clinical research trial.

Pisano previously led the Digital Mammography Screening Trial (DMIST) — which accrued 49,528 women to compare effectiveness of digital mammography to film mammography. DMIST results, published in the New England Journal of Medicine in 2005,1 dramatically changed breast cancer screening guidelines and reimbursement.

For more information: www.acr.org

Reference

1. Pisano E.D., Gatsonis C., Hendrick E., et al. Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening. New England Journal of Medicine, Oct. 27, 2005. DOI: 10.1056/NEJMoa052911

Related Content

VolparaDensity With Tyrer-Cuzick Model Improves Breast Cancer Risk Stratification
News | Breast Density | May 22, 2019
Research has demonstrated use of Volpara Solutions' VolparaDensity software in combination with the Tyrer-Cuzick Breast...
Life Image and Bialogics Analytics Partner to Deliver Imaging Business Intelligence
News | Analytics Software | May 21, 2019
Life Image and business intelligence analytics provider Bialogics Analytics have formed a strategic partnership that...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
AI Detects Unsuspected Lung Cancer in Radiology Reports, Augments Clinical Follow-up
News | Artificial Intelligence | May 20, 2019
Digital Reasoning announced results from its automated radiology report analytics research. In a series of experiments...
New Study Evaluates Head CT Examinations and Patient Complexity
News | Neuro Imaging | May 17, 2019
Computed tomography (CT) of the head uses special X-ray equipment to help assess head injuries, dizziness and other...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...
3 Recommendations to Better Understand HIPAA Compliance
Feature | Information Technology | May 17, 2019 | Carol Amick
According to the U.S.
Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
Icon Launches New Clinical Trial Patient Engagement Platform
Technology | Patient Engagement | May 14, 2019
Icon plc announced the release of its web-based clinical trial patient engagement platform, to provide patients with...